Enliven Therapeutics
ELVN
#4337
Rank
A$3.66 B
Marketcap
A$61.27
Share price
-2.01%
Change (1 day)
129.03%
Change (1 year)

Enliven Therapeutics (ELVN) - Net assets

Net assets on the balance sheet as of December 2025 : A$0.64 Billion

According to Enliven Therapeutics's latest financial reports the company has A$0.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enliven Therapeutics - Net assets on balance sheet (from 2021 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$A$0.68 B37.75%
2024-12-31$A$0.49 B38.01%
2023-12-31$A$0.36 B-419.71%
2022-12-31$-A$0.12 Billion90.84%
2021-12-31$-A$59.16 Million124.03%
2020-12-31$-A$26.41 Million